Search

Your search keyword '"M. Mira Flores"' showing total 10 results
Start Over Author "M. Mira Flores"
10 results on '"M. Mira Flores"'

1. A European prospective observational study of enzalutamide (ENZA) in patients with metastatic castration-resistant prostate cancer (mCRPC): PREMISE

Author

H. Payne, A. Robinson, B. Rappe, S. Hilman, U. De Giorgi, S. Joniau, R. Bordonaro, S. Mallick, L. Dourthe, M. Mira Flores, J. Gumà, B. Baron, A. Duran, A. Pranzo, A. Serikoff, and M. De Santis

Subjects
Diseases of the genitourinary system. Urology, RC870-923, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Published
2020
Full Text
View/download PDF

2. Pain outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving enzalutamide (ENZA) in a real-world setting: PREMISE

Author

D. Mott, M. Herdman, A. Robinson, B. Rappe, S. Hilman, U. De Giorgi, S. Joniau, R. Bordonaro, S. Mallick, L-M. Dourthe, M. Mira Flores, J. Gumà, H. Payne, M. De Santis, B. Baron, A. Duran, A. Pranzo, A. Serikoff, and M. Pavesi

Subjects
Diseases of the genitourinary system. Urology, RC870-923, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Published
2020
Full Text
View/download PDF

3. Pain outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving enzalutamide (ENZA) in a real-world setting: PREMISE

Author

U. De Giorgi, M. De Santis, S. Mallick, M. Mira Flores, Aurea Duran, M. Herdman, J. Gumà, H. Payne, Roberto Bordonaro, A. Pranzo, S. Joniau, A. Serikoff, Serena Hilman, Benoit Baron, Marco Pavesi, L-M. Dourthe, D. Mott, Angus Robinson, and B. Rappe

Subjects
Oncology, medicine.medical_specialty, business.industry, Urology, Castration resistant, medicine.disease, lcsh:Diseases of the genitourinary system. Urology, lcsh:RC870-923, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, chemistry.chemical_compound, Prostate cancer, chemistry, Internal medicine, medicine, Enzalutamide, In patient, business
Published
2020

5. A European prospective observational study of enzalutamide (ENZA) in patients with metastatic castration-resistant prostate cancer (mCRPC): PREMISE

Author

Roberto Bordonaro, Aurea Duran, B. Rappe, L. Dourthe, M. De Santis, S. Joniau, U. De Giorgi, M. Mira Flores, Serena Hilman, J. Gumà, A. Serikoff, H. Payne, Benoit Baron, S. Mallick, Angus Robinson, and A. Pranzo

Subjects
Oncology, medicine.medical_specialty, business.industry, Urology, Castration resistant, lcsh:Diseases of the genitourinary system. Urology, lcsh:RC870-923, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, lcsh:RC254-282, chemistry.chemical_compound, Prostate cancer, chemistry, Internal medicine, medicine, Enzalutamide, Observational study, In patient, business
Published
2020
Full Text
View/download PDF

7. A Phase IIB Trial of Docetaxel Concurrent with Radiation Therapy Plus Hormonotherapy Versus Radio Hormonotherapy in High-Risk Localized Prostate Cancer: Late Toxicity Analysis

Author

J. Maldonado, M. Mira Flores, A. Bejar Luque, Joan Carles, J. Jove-Teixido, G. Sancho Pardo, M. Bonet, A. Rovirosa, and Palmira Foro

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Radiation, business.industry, medicine.medical_treatment, medicine.disease, PHASE IIB TRIAL, Radiation therapy, Late toxicity, Prostate cancer, Docetaxel, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, business, medicine.drug
Published
2018
Full Text
View/download PDF

8. 747 poster CARDIAC TOXICITY IN PATIENTS WITH BREAST CANCER UNDERGOING CONCOMITANT RADIOTHERAPY AND TRASTUZUMAB

Author

Ripol, J.A. Carceller, C. Monfà Binefa, J.E. Baquedano Baquedano, M. Mira Flores, E. Garcia Alonso, V. Garcia Reglero, Erik Aguirre, and M. Colomer

Subjects
Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Hematology, medicine.disease, Radiation therapy, Breast cancer, Trastuzumab, Concomitant, Cardiac toxicity, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, In patient, business, medicine.drug
Published
2011
Full Text
View/download PDF

9. 1088 Non-small-cell lung cancer (NSCLC) treated with chemotherapy: Survival analysis of 50 patients

Author

J.A. Carceller Vidal, A. Balil Gilart, E. Garcia Alonso, S. Morales Murillo, and M. Mira Flores

Subjects
Cisplatin, Cancer Research, medicine.medical_specialty, Chemotherapy, Ifosfamide, Lung, business.industry, medicine.medical_treatment, non-small cell lung cancer (NSCLC), medicine.disease, Gastroenterology, Surgery, medicine.anatomical_structure, Oncology, Internal medicine, Medicine, High incidence, Stage (cooking), business, Survival analysis, medicine.drug
Abstract

We assessed the outcome in 50 patients with NSCLC treated from June 1991 through June 1994 with multiagent chemotherapy (Cisplatin 100 mg/m 2 , Ifosfamide 3 g/m 2 , and Mitomicine 6 mg/m 2 , given every 21 days). We studied too, the survival and the recurrence. There were 47 males and three females, and their ages ranged from 36 to 78 years. According to the staging, 3 were in Stage I, 3 in stage II, 3 in stage IlIA, 26 in Satge IlIB, and 4 in Stage IV. The actuarial survival at 1 year for the 50 patients was 42%, with a median survival of 8 months. In the total group, 24 responded (4 CR, 20 PR), with an actuarial survival at 12 months of 68% and a median survival of 15 months; vs 12% and 6 months for patients who did not respond, respectively. Recurrence was observed in 15 patients, five In the CNS, four in the lung, three in the liver, two in bone and one supraclavicular. Conclusions Patients who responded to chemotherapy showed a significantly longer survival than non-responding. It is remarkable the high incidence of brain and local recurrence, that could justify the use of Conbination with other local treatments.

Published
1995
Full Text
View/download PDF

10. Impact of covid-19 on patients in radiotherapy oncology departaments in Spain.

Author

Samper Ots PM, Zapatero Ortuño J, Pedraza Fernández S, Mayrata Canellas E, González San Segundo C, Campo Vargas M, Caballero B, Ramos Albiac M, Vázquez Masedo G, Álvarez B, Rodríguez Villalba S, Muñoz Miguelañez T, Diezhandino Garcia P, Sancho G, Guzmán Gómez L, Tripero J, Rico Oses MR, Ibañez Villoslada C, Soler Rodríguez AMS, Chust ML, Fondevilla Soler A, Lozano Martin EM, Morillo Macias V, Fuentes Sánchez C, Torrado Moya L, Fernández López J, Solé JM, Guijarro Verdú M, Mira Flores M, Wals A, and Expósito Hernández J

Subjects
Humans, SARS-CoV-2, Spain, COVID-19, Neoplasms radiotherapy, Radiation Oncology
Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results